First do no harm-beware the risk of therapeutic plasma exchange in severe COVID-19.
作者信息
Stahl Klaus, Bode Christian, David Sascha
机构信息
Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
Department of Anaesthesiology and Critical Care, University Medicine Bonn, Bonn, Germany.
出版信息
Crit Care. 2020 Jun 18;24(1):363. doi: 10.1186/s13054-020-03070-7.
Abstract
摘要
相似文献
1
First do no harm-beware the risk of therapeutic plasma exchange in severe COVID-19.首要的是不造成伤害——谨防重症新型冠状病毒肺炎患者进行治疗性血浆置换的风险。
Crit Care. 2020 Jun 18;24(1):363. doi: 10.1186/s13054-020-03070-7.
2
Therapeutic Plasma Exchange-Neutralizing Antibody Combination Therapy for Severe Coronavirus Disease 2019.治疗性血浆置换-中和抗体联合疗法治疗重症2019冠状病毒病
J Infect Dis. 2020 Jul 6;222(3):509-510. doi: 10.1093/infdis/jiaa312.
3
Response to Malkovsky.对马尔科夫斯基的回应。
J Infect Dis. 2020 Jul 6;222(3):510-511. doi: 10.1093/infdis/jiaa313.
4
Get rid of the bad first: Therapeutic plasma exchange with convalescent plasma for severe COVID-19.先去除有害物质：采用恢复期血浆进行治疗性血浆置换治疗重症新型冠状病毒肺炎。
Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):12526-12527. doi: 10.1073/pnas.2006691117. Epub 2020 May 12.
5
Therapeutic plasma exchange as a rescue therapy in patients with coronavirus disease 2019: a case series.治疗性血浆置换作为2019冠状病毒病患者的挽救治疗：病例系列
Pol Arch Intern Med. 2020 May 29;130(5):455-458. doi: 10.20452/pamw.15340. Epub 2020 May 7.
6
Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure.治疗性血浆置换作为脓毒性休克的常规疗法以及作为新冠病毒病的实验性治疗方法：我们并不确定。
Crit Care. 2020 May 15;24(1):226. doi: 10.1186/s13054-020-02943-1.
7
A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19.一种针对新型冠状病毒的新型治疗方法：支持对暴发性新型冠状病毒肺炎使用治疗性血浆置换的观点。
Crit Care. 2020 Apr 2;24(1):128. doi: 10.1186/s13054-020-2836-4.
8
Therapeutic plasma exchange in life-threatening COVID-19 and associated cytokine release syndrome.用于治疗危及生命的新型冠状病毒肺炎及相关细胞因子释放综合征的治疗性血浆置换
J Formos Med Assoc. 2020 Dec;119(12):1888-1889. doi: 10.1016/j.jfma.2020.07.016. Epub 2020 Jul 13.
9
Reply to Letter to the Editor: Therapeutic plasma exchange resolving COVID-19 related ARDS.致编辑的信的回复：治疗性血浆置换术治疗新冠病毒病相关急性呼吸窘迫综合征
J Formos Med Assoc. 2020 Dec;119(12):1890-1892. doi: 10.1016/j.jfma.2020.07.031. Epub 2020 Jul 28.
10
COVID-19 Pandemic Hemoperfusion Therapy Versus Plasma Exchange Therapy in Intensive Care.重症监护中COVID-19大流行的血液灌流疗法与血浆置换疗法对比
Iran J Allergy Asthma Immunol. 2020 May 17;19(S1):7-9. doi: 10.18502/ijaai.v19i(s1.r1).2848.
引用本文的文献
1
Plasma Adsorption with the MTx.100 Column in Critically Ill COVID-19 Patients: A Prospective Study and Propensity Score Analysis.MTx.100柱血浆吸附治疗重症COVID-19患者：一项前瞻性研究和倾向评分分析
J Intensive Care Med. 2025 Mar;40(3):314-319. doi: 10.1177/08850666241280031. Epub 2024 Sep 12.
2
A randomised controlled trial of plasma exchange compared to standard of care in the treatment of severe COVID-19 infection (COVIPLEX).一项比较血浆置换与标准治疗在严重 COVID-19 感染（COVIPLEX）治疗中的随机对照试验。
Sci Rep. 2024 Jul 23;14(1):16876. doi: 10.1038/s41598-024-67028-3.
3
Plasma exchange and COVID 19.血浆置换与新型冠状病毒肺炎
Transfus Apher Sci. 2022 Dec;61(6):103598. doi: 10.1016/j.transci.2022.103598. Epub 2022 Nov 12.
4
Acute Kidney Injury and Blood Purification Techniques in Severe COVID-19 Patients.重症 COVID-19 患者的急性肾损伤与血液净化技术
J Clin Med. 2022 Oct 25;11(21):6286. doi: 10.3390/jcm11216286.
5
Efficacy of therapeutic plasma exchange in severe COVID-19 disease: A meta-analysis.治疗性血浆置换在重症 COVID-19 疾病中的疗效：一项荟萃分析。
Vox Sang. 2023 Jan;118(1):49-58. doi: 10.1111/vox.13367. Epub 2022 Oct 18.
6
On Therapeutic Plasma Exchange Against Severe COVID-19-Associated Pneumonia: An Observational Clinical Study.关于治疗性血浆置换治疗重症新型冠状病毒肺炎相关肺炎的观察性临床研究。
Front Nutr. 2022 Feb 22;9:809823. doi: 10.3389/fnut.2022.809823. eCollection 2022.
7
Therapeutic plasma exchange followed by convalescent plasma transfusion in severe and critically ill COVID-19 patients: A single centre non-randomized controlled trial.重症和危重症 COVID-19 患者采用治疗性血浆置换联合恢复期血浆输注：一项单中心非随机对照试验
Exp Ther Med. 2022 Jan;23(1):76. doi: 10.3892/etm.2021.10999. Epub 2021 Nov 24.
8
Application of extracorporeal therapies in critically ill COVID-19 patients.体外治疗在危重症 COVID-19 患者中的应用。
J Zhejiang Univ Sci B. 2021;22(9):701-717. doi: 10.1631/jzus.B2100344.
9
Neuromuscular complications of coronavirus disease-19.新型冠状病毒疾病的神经肌肉并发症。
Curr Opin Neurol. 2021 Oct 1;34(5):669-674. doi: 10.1097/WCO.0000000000000970.
10
Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β.早期给予干扰素-β以利用I型干扰素免疫对抗新型冠状病毒。
J Clin Immunol. 2021 Oct;41(7):1425-1442. doi: 10.1007/s10875-021-01068-6. Epub 2021 Jun 8.
本文引用的文献
1
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.新型冠状病毒肺炎的肺血管内皮细胞炎症、血栓形成和血管生成。
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
2
Endothelial cell infection and endotheliitis in COVID-19.新型冠状病毒肺炎中的内皮细胞感染与内皮炎
Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.
3
A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19.一种针对新型冠状病毒的新型治疗方法：支持对暴发性新型冠状病毒肺炎使用治疗性血浆置换的观点。
Crit Care. 2020 Apr 2;24(1):128. doi: 10.1186/s13054-020-2836-4.
4
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.5 例危重症 COVID-19 患者接受恢复期血浆治疗。
JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.
5
Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock.治疗性血浆置换对感染性休克内皮激活和凝血相关参数的影响。
Crit Care. 2020 Mar 2;24(1):71. doi: 10.1186/s13054-020-2799-5.
6
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue.临床实践中治疗性血液成分单采术的使用指南——美国血液成分单采学会写作委员会基于证据的方法：第八期特刊
J Clin Apher. 2019 Jun;34(3):171-354. doi: 10.1002/jca.21705.
7
Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers.早期治疗性血浆置换在感染性休克中的应用：一项关注安全性、血液动力学、血管屏障功能和生物标志物的前瞻性开放标签非随机初步研究。
Crit Care. 2018 Oct 30;22(1):285. doi: 10.1186/s13054-018-2220-9.
8
Use of therapeutic plasma exchange as a rescue therapy in 2009 pH1N1 influenza A--an associated respiratory failure and hemodynamic shock.在 2009 年 pH1N1 流感 A 中，使用治疗性血浆置换作为抢救疗法——与呼吸衰竭和血流动力学休克相关。
Pediatr Crit Care Med. 2011 Mar;12(2):e87-9. doi: 10.1097/PCC.0b013e3181e2a569.
9
Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial.严重脓毒症和脓毒性休克中的血浆置换：一项前瞻性、随机、对照试验。
Intensive Care Med. 2002 Oct;28(10):1434-9. doi: 10.1007/s00134-002-1410-7. Epub 2002 Jul 23.
Zotero 插件